Market Research

Contraceptives Market (Product: Contraceptive Drugs [Oral Contraceptives, Contraceptive Injectable, and Topical Contraceptive Patch] and Contraceptive Devices [Male Contraceptive Devices and Female Contraceptive Devices]; and Distribution Channel: Hospita

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 189 Pages Transparency Market Research Pvt. Ltd. January, 2022 TNPR17063872
Best Price Guarantee
Price from $5,795
Length 189 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date January, 2022
SKU TNPR17063872

Contraceptives Market (Product: Contraceptive Drugs [Oral Contraceptives, Contraceptive Injectable, and Topical Contraceptive Patch] and Contraceptive Devices [Male Contraceptive Devices and Female Contraceptive Devices]; and Distribution Channel: Hospitals Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Contraceptives Market – Scope of Report
TMR’s report on the global contraceptives market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global contraceptives market for the period 2017–2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global contraceptives market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global contraceptives market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global contraceptives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global contraceptives market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global contraceptives market.

The report delves into the competition landscape of the global contraceptives market. Key players operating in the global contraceptives market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global contraceptives market that have been profiled in this report.

Key Questions Answered in Contraceptives Market Report
What is the scope of growth of product companies in the global contraceptives market?
What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
What is the influence of changing trends in technologies on the global contraceptives market?
Will North America to be the most profitable market for contraceptives devices providers?
Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
Which are the leading companies in the global contraceptives market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global contraceptives market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global contraceptives market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the contraceptives market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the contraceptives market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global contraceptives market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global contraceptives market more reliably and accurately.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Contraceptives Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Contraceptives Market Analysis and Forecast, 2017–2028
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Global Contraceptives Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
5. Global Contraceptives Market Analysis and Forecast, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast, by Product, 2017–2028
5.4.1. Contraceptives Drugs
5.4.1.1. Oral Contraceptives
5.4.1.1.1. Combined Contraceptives
5.4.1.1.2. Mini-pills
5.4.1.2. Contraceptive Injectable
5.4.1.3. Topical Contraceptive Patch
5.4.2. Contraceptive Devices
5.4.2.1. Male Contraceptive Devices
5.4.2.2. Female Contraceptive Devices
5.4.2.2.1. Female Condoms
5.4.2.2.2. Contraceptive Diaphragms
5.4.2.2.3. Contraceptive Sponges
5.4.2.2.4. Contraceptive Vaginal Rings
5.4.2.2.5. Intrauterine Devices
5.4.2.2.6. Sub-dermal Contraceptives Implants
5.4.2.2.7. Non-Surgical Permanent Contraception Devices
5.5. Market Attractiveness Analysis, By Product
6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast, by Distribution Channel, 2017–2028
6.4.1. Hospital Pharmacy
6.4.1.1. Public
6.4.1.2. Private
6.4.2. Independent Pharmacy
6.4.3. Online Platform
6.4.4. Clinics
6.4.5. Others
6.5. Market Attractiveness Analysis, By Distribution Channel
7. Global Contraceptives Market Analysis and Forecast, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast, by Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis, By Country/Region
8. North America Contraceptives Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Policies and Regulations
8.1.3. Key Trends
8.2. Market Value Forecast, by Product, 2017–2028
8.2.1. Contraceptive Drugs
8.2.1.1. Oral Contraceptives
8.2.1.1.1. Combined Contraceptives
8.2.1.1.2. Mini-pills
8.2.1.2. Contraceptive Injectable
8.2.1.3. Topical Contraceptive Patch
8.2.2. Contraceptive Devices
8.2.2.1. Male Contraceptive Devices
8.2.2.2. Female Contraceptive Devices
8.2.2.2.1. Female Condoms
8.2.2.2.2. Contraceptive Diaphragms
8.2.2.2.3. Contraceptive Sponges
8.2.2.2.4. Contraceptive Vaginal Rings
8.2.2.2.5. Intrauterine Devices
8.2.2.2.6. Sub-dermal Contraceptives Implants
8.2.2.2.7. Non-Surgical Permanent Contraception Devices
8.3. Market Value Forecast, by Distribution Channel, 2017–2028
8.3.1. Hospital Pharmacy
8.3.1.1. Public
8.3.1.2. Private
8.3.2. Independent Pharmacy
8.3.3. Online Platform
8.3.4. Clinics
8.3.5. Others
8.4. Market Value Forecast, by Country, 2017–2028
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By Distribution Channel
8.5.3. By Country
9. Europe Contraceptives Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast, by Product, 2017–2028
9.2.1. Contraceptive Drugs
9.2.1.1. Oral Contraceptives
9.2.1.1.1. Combined Contraceptives
9.2.1.1.2. Mini-pills
9.2.1.2. Contraceptive Injectable
9.2.1.3. Topical Contraceptive Patch
9.2.2. Contraceptive Devices
9.2.2.1. Male Contraceptive Devices
9.2.2.2. Female Contraceptive Devices
9.2.2.2.1. Female Condoms
9.2.2.2.2. Contraceptive Diaphragms
9.2.2.2.3. Contraceptive Sponges
9.2.2.2.4. Contraceptive Vaginal Rings
9.2.2.2.5. Intrauterine Devices
9.2.2.2.6. Sub-dermal Contraceptives Implants
9.2.2.2.7. Non-Surgical Permanent Contraception Devices
9.3. Market Value Forecast, by Distribution Channel, 2017–2028
9.3.1. Hospital Pharmacy
9.3.1.1. Public
9.3.1.2. Private
9.3.2. Independent Pharmacy
9.3.3. Online Platform
9.3.4. Clinics
9.3.5. Others
9.4. Market Value Forecast, by Country/Sub-region, 2017–2028
9.4.1. Germany
9.4.2. France
9.4.3. U.K.
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country/Sub-region
10. Asia Pacific Contraceptives Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast, by Product, 2017–2028
10.2.1. Contraceptive Drugs
10.2.1.1. Oral Contraceptives
10.2.1.1.1. Combined Contraceptives
10.2.1.1.2. Mini-pills
10.2.1.2. Contraceptive Injectable
10.2.1.3. Topical Contraceptive Patch
10.2.2. Contraceptive Devices
10.2.2.1. Male Contraceptive Devices
10.2.2.2. Female Contraceptive Devices
10.2.2.2.1. Female Condoms
10.2.2.2.2. Contraceptive Diaphragms
10.2.2.2.3. Contraceptive Sponges
10.2.2.2.4. Contraceptive Vaginal Rings
10.2.2.2.5. Intrauterine Devices
10.2.2.2.6. Sub-dermal Contraceptives Implants
10.2.2.2.7. Non-Surgical Permanent Contraception Devices
10.3. Market Value Forecast, by Distribution Channel, 2017–2028
10.3.1. Hospital Pharmacy
10.3.1.1. Public
10.3.1.2. Private
10.3.2. Independent Pharmacy
10.3.3. Online Platforms
10.3.4. Clinics
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Latin America Contraceptives Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2. Market Value Forecast, by Product, 2017–2028
11.2.1. Contraceptive Drugs
11.2.1.1. Oral Contraceptives
11.2.1.1.1. Combined Contraceptives
11.2.1.1.2. Mini-pills
11.2.1.2. Contraceptive Injectable
11.2.1.3. Topical Contraceptive Patch
11.2.2. Contraceptive Devices
11.2.2.1. Male Contraceptive Devices
11.2.2.2. Female Contraceptive Devices
11.2.2.2.1. Female Condoms
11.2.2.2.2. Contraceptive Diaphragms
11.2.2.2.3. Contraceptive Sponges
11.2.2.2.4. Contraceptive Vaginal Rings
11.2.2.2.5. Intrauterine Devices
11.2.2.2.6. Sub-dermal Contraceptives Implants
11.2.2.2.7. Non-Surgical Permanent Contraception Devices
11.3. Market Value Forecast, by Distribution Channel, 2017–2028
11.3.1. Hospital Pharmacy
11.3.1.1. Public
11.3.1.2. Private
11.3.2. Independent Pharmacy
11.3.3. Online Platforms
11.3.4. Clinics
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Middle East and Africa Contraceptives Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast, by Product, 2017–2028
12.2.1. Contraceptive Drugs
12.2.1.1. Oral Contraceptives
12.2.1.1.1. Combined Contraceptives
12.2.1.1.2. Mini-pills
12.2.1.2. Contraceptive Injectable
12.2.1.3. Topical Contraceptive Patch
12.2.2. Contraceptive Devices
12.2.2.1. Male Contraceptive Devices
12.2.2.2. Female Contraceptive Devices
12.2.2.2.1. Female Condoms
12.2.2.2.2. Contraceptive Diaphragms
12.2.2.2.3. Contraceptive Sponges
12.2.2.2.4. Contraceptive Vaginal Rings
12.2.2.2.5. Intrauterine Devices
12.2.2.2.6. Sub-dermal Contraceptives Implants
12.2.2.2.7. Non-Surgical Permanent Contraception Devices
12.3. Market Value Forecast, by End User, 2017–2028
12.3.1. Hospital Pharmacy
12.3.1.1. Public
12.3.1.2. Private
12.3.2. Independent Pharmacy
12.3.3. Online Platform
12.3.4. Clinics
12.3.5. Others
12.4. Market Value Forecast, by Country /Sub-region, 2017–2028
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East and Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis, by Company, 2020
13.3. Company Profiles
13.3.1. Merck & Co., Inc.
13.3.1.1. Overview
13.3.1.2. Financials
13.3.1.3. Recent Developments
13.3.1.4. Strategy
13.3.2. Cipla, Inc.
13.3.2.1. Overview
13.3.2.2. Financials
13.3.2.3. Recent Developments
13.3.2.4. Strategy
13.3.3. Allergan plc
13.3.3.1. Overview
13.3.3.2. Financials
13.3.3.3. Recent Developments
13.3.3.4. Strategy
13.3.4. Bayer AG
13.3.4.1. Overview
13.3.4.2. Financials
13.3.4.3. Recent Developments
13.3.4.4. Strategy
13.3.5. HLL Lifecare Limited
13.3.5.1. Overview
13.3.5.2. Financials
13.3.5.3. Recent Developments
13.3.5.4. Strategy
13.3.6. Mankind Pharma
13.3.6.1. Overview
13.3.6.2. Financials
13.3.6.3. Recent Developments
13.3.6.4. Strategy
13.3.7. Pfizer, Inc.
13.3.7.1. Overview
13.3.7.2. Financials
13.3.7.3. Recent Developments
13.3.7.4. Strategy
13.3.8. Teva Pharmaceutical Industries Ltd.
13.3.8.1. Overview
13.3.8.2. Financials
13.3.8.3. Recent Developments
13.3.8.4. Strategy
13.3.9. Mithra Pharmaceuticals
13.3.9.1. Overview
13.3.9.2. Financials
13.3.9.3. Recent Developments
13.3.9.4. Strategy
13.3.10. Janssen Pharmaceutical Company
13.3.10.1. Overview
13.3.10.2. Financials
13.3.10.3. Recent Developments
13.3.10.4. Strategy
13.3.11. Reckitt Benckiser Group plc
13.3.11.1. Overview
13.3.11.2. Financials
13.3.11.3. Recent Developments
13.3.11.4. Strategy

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings